Immunological monitoring in transplant-ineligible myeloma patients treated with lenalidomide
Not Applicable
- Conditions
- Multiple myeloma
- Registration Number
- JPRN-UMIN000034399
- Lead Sponsor
- Kyoto University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
A patient who is judged to be inappropriate to participate in this study by the attending physician.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Best therapeutic effect
- Secondary Outcome Measures
Name Time Method Immunological parameters, progression-free survival, overall survival, time to next treatment, safety